Social Relationships and Accelerated Aging in Hematopoietic Cell Transplant Survivors

Medical College of Wisconsin

Status: Enrolling

Conditions: Hematopoietic and Lymphoid Cell Neoplasm

Treatments: Other: Questionnaire Administration; Other: Electronic Health Record Review; Procedure: Biospecimen Collection

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT04892823

43000 (Other Identifier)

K01AG065485 (U.S. NIH Grant/Contract)

NCI-2021-02616 (Registry Identifier)

Details and patient eligibility

About

This project aims to elucidate the important protective elements of social relationships and identify concrete, modifiable behavioral factors that contribute to biological and phenotypic aging in hematopoietic cell transplantation (HCT) survivors and can be used to develop biologically informed interventions to improve quality of life and prolong the healthspan of individuals with accelerated aging.

Full description

PRIMARY OBJECTIVES:

I. Examine associations between social support, strain, and isolation and phenotypic aging over the 1-year recovery period.

II. Examine associations between social support, strain, and isolation and biological aging over the 1-year recovery period.

III. Test biological aging as a mediator linking social processes and phenotypic aging.

EXPLORATORY OBJECTIVE:

I. Test sex differences in Aims 1 and 2.

OUTLINE:

Adopting a prospective design, participants will complete comprehensive assessments of social processes at 100 days and 1 year after HCT that combine reports of social support, strain, and isolation with a naturalistic observation tool, the Electronically Activated Recorder (EAR), which captures ambient sound bites to assess social interactions in survivors' daily lives16. At each time point, participants will also provide reports of symptoms to characterize phenotypic aging, including cognitive, physical, and functional complaints, and blood samples to assess biological aging, including cellular senescence, DNA damage, SASP, and cellular stress using genome-wide RNA sequencing. Relevant clinical information that could influence biological aging will also be collected from patients' medical records to consider as covariates.

Enrollment: 110 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Aged 18 years and older who are competent to give their informed consent.
• Ability to read, speak, and understand English.
• Received a hematopoietic cell transplant within the previous 100 days.

Exclusion criteria

• Less then Aged 18 years and older who are competent to give their informed consent.
• Cannot read, speak, and understand English.
• Has not received a hematopoietic cell transplant within the previous 100 days.

Trial design

110 participants in 1 patient group

Supportive care (EAR, questionnaires, biospecimen collection)

Description:

Participants will complete comprehensive assessments of social processes at 100 days and 1 year after HCT that combine reports of social support, strain, and isolation with a naturalistic observation tool, the Electronically Activated Recorder (EAR), which captures ambient sound bites to assess social interactions in survivors' daily lives. At each time point, participants will also provide reports of symptoms to characterize phenotypic aging, including cognitive, physical, and functional complaints, and blood samples to assess biological aging, including cellular senescence, DNA damage, SASP, and cellular stress using genome wide RNA sequencing. Relevant clinical information that could influence biological aging will also be collected from patients' medical records to consider as covariates.

Treatment:

Procedure: Biospecimen Collection

Other: Electronic Health Record Review

Other: Questionnaire Administration